"/> Novus Biologicals™ Peptide bloquant d’anticorps BTK | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps BTK

Réf. : BL-RE-051309Réf. fabricant : 18288745
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
695
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76596. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the amino terminus of human BTK (NT) .

Points forts

Source

Synthetic

(Accession #: Q06187) The BTK Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-051309
Réf. fabricant18288745
Gene ID (Entrez)695
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76596. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneAgammaglobulinaemia tyrosine kinase, AGMX1MGC126262, AT, ATKIMD1, B-cell progenitor kinase, BPK, Bruton agammaglobulinemia tyrosine kinase, Bruton tyrosine kinase, dominant-negative kinase-deficient Brutons tyrosine kinase, EC 2.7.10, EC 2.7.10.2, PSCTK1, tyrosine-protein kinase BTK, XLAMGC126261
Symbole de gène(s)BTK
Type de produitBTK
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the amino terminus of human BTK (NT)
Une question, une configuration particulière ?
Contactez-nous pour un devis.